Neupulse wearable device for Tourette Syndrome wins Knowledge Exchange and Impact award

    
February 12, 2024

The University of Nottingham's Knowledge Exchange and Impact Awards recently honoured Professor Stephen Jackson's team at the University of Nottingham and Neurotherapeutics Ltd with the Science Faculty's award for Professor Stephen Jackson's groundbreaking research leading to the innovative Neupulse technology and for Neurotherapeutics Ltd’s work resulting in the Neupulse technology being developed into a wearable device to alleviate symptoms for individuals with Tourette Syndrome.

The award celebrates the project's societal impact, highlighting the device's global potential to positively influence the lives of those living with Tourette Syndrome and their families.

It recognised the collaborative efforts from researchers at the University of Nottingham and the team at Neurotherapeutics Ltd in striving to make a meaningful difference.

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road
Nottingham 
England
NG7 2TU

Tourettes Friendly Organisation
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action.

Privacy Notice       Cookies

Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Back to Top
crossmenu